Immix Biopharma (IMMX) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction
All stock predictions
All currency forecasts
All cryptocurrency predictions

This Month Predictions for IMMX stock
Immix Biopharma, Inc. Analysis
IMMX Stock News


Popular stocks
Shopify
MicroAlgo
Boeing
NVIDIA
Tesla
GameStop
Dogness (International)
Riot Blockchain
Alibaba
AMD

TOP Stocks
Microsoft
Apple
Tesla
Alibaba
Amazon
American Airlines
NVIDIA
Adobe

Shares of other companies:
Lyft
T Stamp
Splunk
Color Star Technology
Absci
Aridis Pharmaceuticals
Accenture
Inovio Pharmaceuticals
Nutrien
Genasys


Financial News

Popular Stocks Analysis

Investor's Journal
Understanding Accounting and Bookkeeping Services for Business Success

June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success

Every successful business relies on accurate financial records. From managing cash flow to ensuring compliance with tax regulations, reliable accounting and bookkeeping services…
How much does a Turkish passport cost?

May 27, 2025 How much does a Turkish passport cost?

Turkish citizenship comes with numerous benefits. Once granted, a foreigner can enter 126 countries visa-free, enjoy high-quality healthcare and favorable tax regimes, and…
How Measurement and Mix Modeling Drive Better Business Decisions

May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions

In today’s data-driven business landscape, the ability to accurately measure and optimize marketing efforts has become a critical competitive advantage. As marketing evolves,…
Are you making these mistakes when analyzing candlestick patterns?

May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?

Trading is a very popular endeavor these days, and for good reason, as it is widely accessible and allows individuals to generate additional…
Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

What defines a successful crypto expert? The amount of money earned, the number of luxury cars and international real estate? The presence of…
  1. Home
  2. Stock forecasts
  3. IMMX

Immix Biopharma (IMMX) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: June 18, 2025 (17:01)

Sector: Healthcare

The share price of Immix Biopharma, Inc. (IMMX) now

Latest session on the 17th of June for
Immix Biopharma, Inc. is negative
Trading Volume: 55703
Open: 2.41 /  High: 2.459 /  Low: 2.26
Current value: $2.28
What analysts predict: $7
52-week High/Low: $2.71 / $1.26
50-Day Moving Average: $1.864 — support level today
200-Day Moving Average: $1.873 — support level today

Are you interested in Immix Biopharma, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Immix Biopharma stock price in 2025, 2026, 2027. How much will one Immix Biopharma share be worth in 2025 - 2027?

When should I take profit in Immix Biopharma stock? When should I record a loss on Immix Biopharma stock? What are analysts' forecasts for Immix Biopharma stock? What is the future of Immix Biopharma stock? We forecast Immix Biopharma stock performance using neural networks based on historical data on Immix Biopharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Immix Biopharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Immix Biopharma shares. This happens once a day.


Historical and forecast chart of Immix Biopharma stock

The chart below shows the historical price of Immix Biopharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Immix Biopharma stock price can be found in the table below.

Long-term forecasts by years.

Immix Biopharma is a United States-based clinical stage biopharmaceutical company with a division in Australia (Immix Biopharma Australia).
Immix Biopharma conducts research in the treatment of cancer and inflammatory diseases. The company’s key experimental line, IMX-110, is in phase 1b / 2a clinical trials and is being investigated for efficacy in the treatment of solid tumors. Tests are taking place in the United States and Australia.

Trending Themes in the Healthcare Sector

Immix Biopharma daily forecast for a month

Date Target Pes. Opt. Vol., %
Jun 20 2.27 2.23 2.33 4.39
Jun 21 2.29 2.22 2.32 4.63
Jun 22 2.26 2.21 2.29 3.98
Jun 23 2.22 2.19 2.26 3.46
Jun 24 2.27 2.25 2.32 3.07
Jun 25 2.31 2.29 2.35 3.00
Jun 26 2.31 2.26 2.37 4.87
Jun 27 2.35 2.31 2.42 4.81
Jun 28 2.43 2.41 2.48 3.19
Jun 29 2.41 2.39 2.48 3.71
Jun 30 2.38 2.36 2.45 3.75
Jul 01 2.43 2.41 2.46 2.10
Jul 02 2.50 2.48 2.56 3.23
Jul 03 2.49 2.44 2.52 3.18
Jul 04 2.47 2.41 2.50 3.76
Jul 05 2.47 2.41 2.50 3.77
Jul 06 2.48 2.43 2.51 3.01
Jul 07 2.56 2.52 2.63 4.43
Jul 08 2.46 2.43 2.52 3.65
Jul 09 2.50 2.44 2.57 5.63
Jul 10 2.45 2.39 2.50 4.60
Jul 11 2.47 2.40 2.50 4.17
Jul 12 2.51 2.44 2.53 4.08
Jul 13 2.60 2.55 2.66 4.45
Jul 14 2.62 2.55 2.68 5.30
Jul 15 2.60 2.56 2.63 2.81
Jul 16 2.59 2.57 2.65 3.15
Jul 17 2.61 2.56 2.67 4.07
Jul 18 2.65 2.58 2.70 4.68
Jul 19 2.54 2.49 2.62 5.10

Immix Biopharma Daily Price Targets


Immix Biopharma Stock Forecast 06-20-2025.

Forecast target price for 06-20-2025: $2.27.
Negative dynamics for Immix Biopharma shares will prevail with possible volatility of 4.206%.
Pessimistic target level: 2.23
Optimistic target level: 2.33

Immix Biopharma Stock Forecast 06-21-2025.

Forecast target price for 06-21-2025: $2.29.
Positive dynamics for Immix Biopharma shares will prevail with possible volatility of 4.423%.
Pessimistic target level: 2.22
Optimistic target level: 2.32

Immix Biopharma Stock Forecast 06-22-2025.

Forecast target price for 06-22-2025: $2.26.
Negative dynamics for Immix Biopharma shares will prevail with possible volatility of 3.828%.
Pessimistic target level: 2.21
Optimistic target level: 2.29

Immix Biopharma Stock Forecast 06-23-2025.

Forecast target price for 06-23-2025: $2.22.
Negative dynamics for Immix Biopharma shares will prevail with possible volatility of 3.343%.
Pessimistic target level: 2.19
Optimistic target level: 2.26

Immix Biopharma Stock Forecast 06-24-2025.

Forecast target price for 06-24-2025: $2.27.
Positive dynamics for Immix Biopharma shares will prevail with possible volatility of 2.982%.
Pessimistic target level: 2.25
Optimistic target level: 2.32

Immix Biopharma Stock Forecast 06-25-2025.

Forecast target price for 06-25-2025: $2.31.
Positive dynamics for Immix Biopharma shares will prevail with possible volatility of 2.910%.
Pessimistic target level: 2.29
Optimistic target level: 2.35

IMMX (IMMX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jul. 2.09 1.71 2.36 27.77
Aug. 2.45 2.17 2.86 24.25
Sep. 2.40 2.27 2.85 20.17
Oct. 2.44 2.20 2.69 18.27
Nov. 2.20 1.79 2.33 23.27
Dec. 2.51 2.34 2.83 17.25
Full forecast for 2025

Immix Biopharma forecast for this year


Immix Biopharma Stock Prediction for Jul 2025

An downtrend is forecast for this month with an optimal target price of $2.08728. Pessimistic: $1.71. Optimistic: $2.36


Immix Biopharma Stock Prediction for Aug 2025

An uptrend is forecast for this month with an optimal target price of $2.44796. Pessimistic: $2.17. Optimistic: $2.86


Immix Biopharma Stock Prediction for Sep 2025

An downtrend is forecast for this month with an optimal target price of $2.39509. Pessimistic: $2.27. Optimistic: $2.85


Immix Biopharma Stock Prediction for Oct 2025

An uptrend is forecast for this month with an optimal target price of $2.43532. Pessimistic: $2.20. Optimistic: $2.69


Immix Biopharma Stock Prediction for Nov 2025

An downtrend is forecast for this month with an optimal target price of $2.19569. Pessimistic: $1.79. Optimistic: $2.33


Immix Biopharma Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $2.51187. Pessimistic: $2.34. Optimistic: $2.83



Immix Biopharma (IMMX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 2.28 2.07 2.69 23.14
Feb 2.47 2.12 2.66 20.51
Mar 2.35 1.91 2.49 23.15
Apr 1.94 1.85 2.09 11.39
May 1.78 1.45 1.98 26.80
Jun 1.40 1.14 1.55 26.11
Jul 1.68 1.45 1.76 17.36
Aug 1.60 1.51 1.79 15.68
Sep 1.85 1.51 2.02 25.07
Oct 2.23 1.96 2.58 24.08
Nov 2.00 1.83 2.10 12.80
Dec 2.47 2.09 2.64 20.64
Full forecast for 2026

Immix Biopharma (IMMX) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 3.03 2.63 3.20 17.74
Feb 2.93 2.46 3.45 28.88
Mar 2.67 2.54 2.97 14.26
Apr 2.58 2.37 2.91 18.70
May 2.38 2.19 2.57 14.87
Jun 2.22 2.11 2.34 9.78
Jul 2.20 1.84 2.40 23.48
Aug 2.60 2.26 2.76 18.11
Sep 2.78 2.65 3.03 12.56
Oct 2.48 2.20 2.60 15.34
Nov 2.67 2.30 3.06 24.70
Dec 2.48 2.21 2.85 22.40
Full forecast for 2027

Immix Biopharma information and performance

Immix Biopharma Address

11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES, CA, US

Market Capitalization: 65 233 000 $

Market capitalization of the Immix Biopharma, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of IMMX shares in the company outstanding by the market price of one share.

EBITDA: -21 699 388 $

EBITDA of Immix Biopharma is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.69

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -0.367

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 27877300

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Immix Biopharma Stock)

Should I Buy Immix Biopharma Shares in 2025 year?

The maximum forecasted share price for next year is $2.47, which is $0.19 higher than the current stock price. By investing in Immix Biopharma shares today for a one-year period, you could achieve a profit of 8.49%. With an investment horizon of up to two years, the target share price is $3.03. resulting in a profit of 33.10% ($0.75 per share).

Does Immix Biopharma pay dividends?

No, it does not

Which economic sector do Immix Biopharma's shares belong to?

Immix Biopharma's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Immix Biopharma's shares?

You can view all the stocks that are part of the same sector as Immix Biopharma's shares in the Healthcare section.


Related stocks from Healthcare sector

RenovoRx, Inc. (RNXT)
Rite Aid Corp. (RAD)
Avantor, Inc. (AVTR)
Centene Corp. (CNC)
BeyondSpring Inc. (BYSI)
EyePoint Pharmaceuticals, Inc. (EYPT)
Charles River Laboratories International, Inc. (CRL)
Novo Nordisk A/S (NVO)
Senseonics Holdings, Inc. (SENS)
Mesoblast Limited (MESO)


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.